Prehospital Blood Transfusion: What Every EMS Provider Needs to Know in 2026

Hemorrhagic shock remains the leading cause of preventable death in trauma patients. For decades, the prehospital standard of care relied on crystalloid fluids to keep patients alive during transport. But over the last several years, the evidence has shifted dramatically, and a growing movement in EMS is rewriting how we manage life-threatening bleeding before the patient ever reaches the emergency department.

Prehospital blood transfusion (PHBT) programs are expanding across the country, backed by new clinical practice guidelines, position statements from NAEMSP, and a rapidly growing body of research. Whether you are working on a ground ambulance in a rural county or staffing a critical care transport unit in a major metro, this is a topic that will shape EMS practice for years to come.

Here is what the latest research says and why it matters for your clinical practice.

The Case Against Crystalloid-First Resuscitation

For years, the default approach to hemorrhagic shock in the field was aggressive crystalloid infusion. Normal saline and lactated Ringer’s were the go-to interventions. The logic was simple: restore circulating volume, maintain blood pressure, and get the patient to definitive care.

The problem? Crystalloids do not carry oxygen. They do not support hemostasis. And when administered in large volumes, they actually contribute to acidosis and coagulopathy, two conditions that worsen outcomes in bleeding patients. Research has consistently shown that trauma patients who receive large-volume crystalloid resuscitation have higher mortality compared to those who receive lower volumes or blood products early in the resuscitation process.

This understanding has driven a fundamental shift in how we think about prehospital hemorrhage management. Rather than simply replacing volume, the goal is now to replace what the patient is actually losing: blood.

What the Latest Evidence Shows

In 2025, NAEMSP published its Prehospital Trauma Compendium position statement on blood product transfusion in trauma. The recommendations were clear and represent a major milestone for the profession. For EMS systems that can support a high-quality transfusion program, NAEMSP now recommends using blood components over crystalloids as the first-line treatment for patients with traumatic life-threatening bleeding in the prehospital setting. The organization also recommends low titer group O whole blood (LTOWB) as the first-choice blood product in these situations.

The evidence supporting these recommendations comes from several landmark studies. The PAMPer trial (Prehospital Air Medical Plasma), a multicenter cluster-randomized trial, demonstrated a survival benefit for trauma patients who received plasma during air medical transport, particularly when transport times exceeded 20 minutes. A secondary analysis found that patients who received both red blood cells and plasma had the greatest survival advantage compared to those who received crystalloids alone.

Additionally, research on LTOWB has shown that it is associated with improved survival to hospital arrival, improved 6-hour survival, and a reduced need for additional blood transfusions after reaching the hospital. Importantly, the data suggest that a larger proportion of LTOWB relative to total blood transfused correlates with increased survival, especially in patients with an elevated probability of death.

On the safety front, research presented at the 2025 NAEMSP meeting found that adverse events from prehospital transfusion are rare in both whole blood and component therapy groups. No transfusion reactions were reported, and complications like DVT and pulmonary embolism occurred at very low rates.

The Adoption Gap

Despite this growing evidence base, adoption remains a significant challenge. According to data published in the Journal of Trauma and Acute Care Surgery, fewer than 1% of 911 ground EMS agencies in the United States have successfully implemented prehospital blood transfusion programs. This is striking when you consider that estimates suggest between 54,000 and 900,000 patients annually could benefit from receiving blood products before arriving at the hospital.

NHTSA has cited research estimating that 37% of trauma patients with severe bleeding could potentially be saved through prompt prehospital blood administration, and that each minute of delay in administering blood increases the risk of death by 11%.

So what is holding things back? The barriers are well documented. They include state-level scope of practice limitations for EMS clinicians, the cost of implementing and maintaining blood product programs, the lack of a centralized national database linking prehospital transfusions to hospital outcomes, and the need for closer collaboration between EMS agencies, blood suppliers, and hospital transfusion services.

Beyond Trauma: Expanding Indications

One of the more exciting developments in prehospital transfusion research is the expansion beyond traditional trauma resuscitation. Early evidence suggests that blood product administration may also improve outcomes in conditions like postpartum hemorrhage and gastrointestinal bleeding, where early volume and clotting factor replacement can be equally critical.

Data from a large metropolitan EMS system showed that over an 18-month period, medical conditions accounted for more than 12% of prehospital whole blood transfusions, demonstrating that the real-world application of these programs already extends well beyond the trauma patient.

What This Means for Your CE

Prehospital blood transfusion touches on pathophysiology, pharmacology, and patient assessment, three pillars of EMS continuing education. Understanding hemorrhagic shock at a deeper level, recognizing the limitations of crystalloid resuscitation, and staying current on evolving transfusion protocols are all essential for providing the best possible patient care.

Even if your agency does not currently carry blood products, the principles behind this research are directly applicable to your daily practice. Recognizing the signs of hemorrhagic shock early. Limiting crystalloid volumes in bleeding patients. Understanding when and how to advocate for rapid transport to a trauma center. These are clinical decisions you make on every shift.

At CE Solutions, we are committed to bringing you research-driven continuing education that keeps you at the forefront of prehospital medicine. Our CAPCE-accredited courses are designed by EMS professionals who understand the realities of field practice, and we update our content regularly to reflect the latest evidence and guidelines.

Explore our full catalog of EMS continuing education courses and take the next step in your professional development. With over 200,000 members and more than 25 years of experience in EMS education, CE Solutions is the platform built for providers who take their practice seriously.

This article is intended for educational purposes and does not constitute medical advice. Always follow your local protocols and medical direction.